SELLAS Life Sciences Group, Inc. (SLS) Social Stream
SELLAS Life Sciences Group Inc (SLS) Price Targets From Analysts
Use the tables below to see what analysts covering SELLAS Life Sciences Group Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 41 weeks, SLS's average price target has gone up $7.33.
Over the past 45 weeks, SLS's average upside potential has been 81.57%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SLS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
SLS's average broker recommendation rating improved by 1 over the prior 31 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, SELLAS Life Sciences Group Inc's number of analysts covering the stock is greater than 14.01% of them.
- In terms of how SELLAS Life Sciences Group Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 342.17% of that group.
- In terms of how SELLAS Life Sciences Group Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 17.52% of that group.
- SLS has a greater average analyst price target than 121.25% of Healthcare stocks.
Is SLS a Buy, Hold or Sell? See the POWR Ratings now!